Cellebrite DI Ltd
NASDAQ:CLBT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cellebrite DI Ltd
Total Current Liabilities
Cellebrite DI Ltd
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Total Current Liabilities
$369.7m
|
CAGR 3-Years
21%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Total Current Liabilities
$166m
|
CAGR 3-Years
5%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
|
N
|
Nice Ltd
TASE:NICE
|
Total Current Liabilities
$887.6m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
9%
|
|
|
Magic Software Enterprises Ltd
NASDAQ:MGIC
|
Total Current Liabilities
$165m
|
CAGR 3-Years
16%
|
CAGR 5-Years
20%
|
CAGR 10-Years
17%
|
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Total Current Liabilities
₪1.4B
|
CAGR 3-Years
13%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
|
|
P
|
Pagaya Technologies Ltd
NASDAQ:PGY
|
Total Current Liabilities
$78.6m
|
CAGR 3-Years
-15%
|
CAGR 5-Years
79%
|
CAGR 10-Years
N/A
|
|
Cellebrite DI Ltd
Glance View
Cellebrite DI Ltd. has carved a niche for itself in the digital intelligence arena, becoming a beacon for law enforcement and government agencies worldwide. Born in Petah Tikva, Israel, the company began its journey focusing on mobile data transfer technology before pivoting to one of the most critical aspects of modern policing—extracting and analyzing data from digital devices. Cellebrite's flagship product, the Universal Forensic Extraction Device (UFED), allows investigators to retrieve a plethora of data from smartphones, tablets, and other devices. This capability is crucial in solving crimes, making Cellebrite an indispensable partner for agencies tackling everything from cybercrime to terrorism. The company’s business model thrives on providing not just the hardware and software tools but also ongoing support and training services. This creates a steady stream of recurring revenue, as agencies continually rely on Cellebrite for updates in response to the ever-evolving digital landscape. Additionally, their subscription-based offerings grant clients access to the latest forensic advancements, embedding Cellebrite deeper into their operational frameworks. By focusing on combining comprehensive data solutions with robust client support, Cellebrite ensures its position as a leader in the digital intelligence domain, weaving its technology into the very fabric of modern investigative processes.
See Also
What is Cellebrite DI Ltd's Total Current Liabilities?
Total Current Liabilities
369.7m
USD
Based on the financial report for Dec 31, 2025, Cellebrite DI Ltd's Total Current Liabilities amounts to 369.7m USD.
What is Cellebrite DI Ltd's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 3Y
21%
Over the last year, the Total Current Liabilities growth was 25%. The average annual Total Current Liabilities growth rates for Cellebrite DI Ltd have been 21% over the past three years .